[
  {
    "criterion": "Suggests a stepwise approach to safely lower warfarin dose, including incremental decreases in dose and monitoring INR levels.",
    "axis": "completeness",
    "point": 8
  },
  {
    "criterion": "Mentions that warfarin dose adjustment in patients with mild hepatic insufficiency requires close monitoring and collaboration with a healthcare provider.",
    "axis": "accuracy",
    "point": 7
  },
  {
    "criterion": "Asks the user for more information about their patient's specific condition to provide a more tailored response.",
    "axis": "context_awareness",
    "point": 5
  },
  {
    "criterion": "Provides a clear and concise explanation of the potential risks and benefits of warfarin dose adjustment in patients with atrial fibrillation and mild hepatic insufficiency.",
    "axis": "communication_quality",
    "point": 6
  },
  {
    "criterion": "Fails to mention the importance of regular INR monitoring and potential complications of warfarin therapy, including bleeding and stroke.",
    "axis": "completeness",
    "point": -8
  },
  {
    "criterion": "Incorrectly states that warfarin dose adjustment can be done without monitoring INR levels or collaboration with a healthcare provider.",
    "axis": "accuracy",
    "point": -9
  },
  {
    "criterion": "Provides a response that is overly complicated or technical, using terms that are not easily understandable by a layperson.",
    "axis": "communication_quality",
    "point": -7
  },
  {
    "criterion": "Fails to address the potential interactions between warfarin and other medications, including anticoagulants and antiplatelet agents.",
    "axis": "completeness",
    "point": -5
  },
  {
    "criterion": "Incorrectly suggests that warfarin dose adjustment can be done solely based on patient age, without considering other factors such as liver function and medication interactions.",
    "axis": "accuracy",
    "point": -8
  },
  {
    "criterion": "Provides a response that is irrelevant to the user's question or does not address their specific concerns.",
    "axis": "context_awareness",
    "point": -6
  },
  {
    "criterion": "Fails to provide a clear plan for monitoring and adjusting warfarin therapy, including the frequency and timing of INR measurements.",
    "axis": "completeness",
    "point": -9
  },
  {
    "criterion": "Incorrectly states that warfarin therapy is safe for all patients with atrial fibrillation, regardless of liver function or other health factors.",
    "axis": "accuracy",
    "point": -10
  },
  {
    "criterion": "Provides a response that is overly optimistic or dismissive of potential risks and complications associated with warfarin therapy.",
    "axis": "communication_quality",
    "point": -5
  }
]